Hazard ratio | p-value | [95% Confidence interval] | ||
---|---|---|---|---|
Gender | Male | 1 | ||
Female | 0.52 | 0.003 | [0.34; 0.80] | |
Age a | <59 y | 1 | ||
59 - 73 y | 1.77 | 0.153 | [0.81; 3.88] | |
>73 y | 2.57 | 0.070 | [0.92; 7.15] | |
Socioeconomic status b (quintile of EDI national scores) | 1: highly favoured | 1 | ||
2: favoured | 0.91 | 0.783 | [0.47; 1.78] | |
3: intermediate level | 1.46 | 0.242 | [0.78; 2.73] | |
4: deprived | 0.61 | 0.171 | [0.30; 1.24] | |
5: highly deprived | 0.74 | 0.429 | [0.36; 1.55] | |
Comorbidity | none | 1 | ||
at least 1 | 0.74 | 0.224 | [0.46; 1.20] | |
Standard International prognostic index c (sIPI) | very good | 1 | ||
good | 1.30 | 0.559 | [0.54; 3.15] | |
poor | 2.61 | 0.041 | [1.04; 6.57] | |
Chemotherapy regimens d | R-CHOP21 or R-CHVP21 | 1 | ||
R- CHOP 14 | 0.57 | 0.246 | [0.22; 1.48] | |
R- ACVBP | 0.97 | 0.956 | [0.32; 2.90] | |
R-mini CHOP or R-mini CHVP | 1.94 | 0.122 | [0.84; 4.48] | |
other | 1.49 | 0.516 | [0.45; 4.99] | |
Relative dose-intensity (RDI) | RDI ≥85% | 1 | ||
RDI <85% | 3.89 | <0.001 | [1.86; 8.14] | |
Place of treatment e | Private centres | 1 | ||
TUMC | 1.88 | 0.068 | [0.95; 3.71] | |
Community hospitals | 1.75 | 0.075 | [0.95; 3.25] | |
Time dependant variables | RDI * Time | 0.998 | 0.024 | [0.997; 0.999] |